Bivalirudin

Product NDC
70511-142
11-digit product format
705110142
Labeler code
70511
Product ID
70511-142_c727199d-f4cd-4658-8fdf-568590beface
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Bivalirudin
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
MAIA Pharmaceuticals, Inc.
Application
NDA211215
Marketing category
NDA
Marketing start
2024-05-27
Substance
BIVALIRUDIN
Active strength
250 mg/1
Pharmacologic classes
Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N211215-001ANGIOMAX RTUBIVALIRUDIN250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25

Orange Book patents#

Current patent rows page 1 of 1 · 4 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N211215-001119039932039-05-20U-38172024-02-21
N211215-001119186222039-05-20U-38172024-03-06
N211215-001119925142039-05-20Drug product2024-05-30
N211215-001124722242039-05-20U-3817Drug product2025-11-20

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-2531067a03dcf5…
2025-08-23 18:47 UTC2025-08N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-256a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-2503ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-252680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-255bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-2579d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-251e350fbaab3a…
2024-05-31 18:47 UTC2024-05N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-258072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-255c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-255d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-254b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-2574a2ff9319b5…
2022-03-09 01:35 UTC2022-03N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-2587673890dc5c…
2021-03-12 10:30 UTC2021-03N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-255aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-258869cabd3fbd…
2020-11-12 02:37 UTC2020-11N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25c0c555d07b60…
2019-12-14 00:12 UTC2019-12N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-253f01610625f2…
2019-09-15 20:21 UTC2019-09N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25b00525d2431f…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-256a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-251c564ffb4f44…
2023-12-20 04:57 UTC2023-12N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-259b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-253f0d92c62455…
2023-05-13 08:27 UTC2023-05N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25053a50430f4f…
2023-01-26 05:58 UTC2023-01N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-253bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-253a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N211215-001ANGIOMAX RTU250MG/50ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2019-07-25a50c72e98297…

Observed Orange Book patent history#

Patent history page 1 of 2 · 49 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-02-19 14:30 UTC2026-02N211215-001119039932039-05-20U-38172024-02-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211215-001119186222039-05-20U-38172024-03-06011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211215-001119925142039-05-20Drug product2024-05-30011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211215-001124722242039-05-20U-3817Drug product2025-11-20011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N211215-001119039932039-05-20U-38172024-02-2131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N211215-001119186222039-05-20U-38172024-03-0631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N211215-001119925142039-05-20Drug product2024-05-3031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N211215-001124722242039-05-20U-3817Drug product2025-11-2031067a03dcf5…
2025-08-23 18:47 UTC2025-08N211215-001119039932039-05-20U-38172024-02-216a471c1ec25d…
2025-08-23 18:47 UTC2025-08N211215-001119186222039-05-20U-38172024-03-066a471c1ec25d…
2025-08-23 18:47 UTC2025-08N211215-001119925142039-05-20Drug product2024-05-306a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N211215-001119039932039-05-20U-38172024-02-21fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N211215-001119186222039-05-20U-38172024-03-06fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N211215-001119925142039-05-20Drug product2024-05-30fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N211215-001119039932039-05-20U-38172024-02-21b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N211215-001119186222039-05-20U-38172024-03-06b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N211215-001119925142039-05-20Drug product2024-05-30b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N211215-001119039932039-05-20U-38172024-02-2103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N211215-001119186222039-05-20U-38172024-03-0603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N211215-001119925142039-05-20Drug product2024-05-3003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N211215-001119039932039-05-20U-38172024-02-212680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N211215-001119186222039-05-20U-38172024-03-062680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N211215-001119925142039-05-20Drug product2024-05-302680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N211215-001119039932039-05-20U-38172024-02-215bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N211215-001119186222039-05-20U-38172024-03-065bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N211215-001119925142039-05-20Drug product2024-05-305bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N211215-001119039932039-05-20U-38172024-02-21d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N211215-001119186222039-05-20U-38172024-03-06d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N211215-001119925142039-05-20Drug product2024-05-30d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N211215-001119039932039-05-20U-38172024-02-21d06236e962d9…
2024-10-29 15:01 UTC2024-10N211215-001119186222039-05-20U-38172024-03-06d06236e962d9…
2024-10-29 15:01 UTC2024-10N211215-001119925142039-05-20Drug product2024-05-30d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N211215-001119039932039-05-20U-38172024-02-2179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N211215-001119186222039-05-20U-38172024-03-0679d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N211215-001119925142039-05-20Drug product2024-05-3079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N211215-001119039932039-05-20U-38172024-02-21301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N211215-001119186222039-05-20U-38172024-03-06301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N211215-001119925142039-05-20Drug product2024-05-30301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N211215-001119039932039-05-20U-38172024-02-211e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N211215-001119186222039-05-20U-38172024-03-061e350fbaab3a…

Additional Listing Data#

Finished product
Yes
Brand name base
Bivalirudin
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BIVALIRUDIN250 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
TN9BEX005GInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1997015Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
c727199d-f4cd-4658-8fdf-568590befaceAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
1c25cd48-e81c-4683-ac07-71f9a642e2bfProduct name920211217
325b79a5-b460-45d7-abfc-c4784f5b0531Product name120191120
48747306-602a-42cc-957b-5b0c69158eeeProduct name120180604
c3370853-5a7f-4c73-a273-26ef0162f2f3Product name120180308
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578bProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70511-142-50Bivalirudin1 in 1 VIAL, SINGLE-DOSEINJECTION, SOLUTION11
70511-142-50Bivalirudin1 in 1 CARTONINJECTION, SOLUTION11
70511-142-84Bivalirudin1 in 1 VIAL, SINGLE-DOSEINJECTION, SOLUTION11
70511-142-84Bivalirudin10 in 1 CARTONINJECTION, SOLUTION101

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70511-142BIVALIRUDIN INJECTION, SOLUTION [MAIA PHARMACEUTICALS, INC.]1Current NDC, 4 package rows20240921_c727199d-f4cd-4658-8fdf-568590beface.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BivalirudinBIVALIRUDINMAIA Pharmaceuticals, Inc.c727199d-f4cd-4658-8fdf-568590beface2024-05-27Warnings, Adverse reactionsExact identifier
application applno (NDA): 211215
application number: NDA211215
ndc (product): 70511-142
BivalirudinBIVALIRUDINPar Health USA, LLC91cf9d00-29e0-4357-a184-f70026c47edb2024-03-01Warnings, Adverse reactionsExact identifier
application applno (NDA): 211215
application number: NDA211215

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1997015bivalirudin 250 MG in 50 ML InjectionPSNc727199d-f4cd-4658-8fdf-568590beface1
199701550 ML bivalirudin 5 MG/ML InjectionSCDc727199d-f4cd-4658-8fdf-568590beface1
1997015bivalirudin 250 MG (as bivalirudin trifluoroacetate 275 MG) per 50 ML InjectionSYc727199d-f4cd-4658-8fdf-568590beface1
1997015bivalirudin 250 MG per 50 ML InjectionSYc727199d-f4cd-4658-8fdf-568590beface1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
70511-142-50705110142501 VIAL, SINGLE-DOSE in 1 CARTON (70511-142-50) / 1 INJECTION, SOLUTION in 1 VIAL, SINGLE-DOSE2024-05-27NoNoCurrent
70511-142-847051101428410 VIAL, SINGLE-DOSE in 1 CARTON (70511-142-84) / 1 INJECTION, SOLUTION in 1 VIAL, SINGLE-DOSE2024-05-27NoNoCurrent